---
document_datetime: 2023-09-21 17:49:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/docetaxel-teva-pharma-epar-all-authorised-presentations_en.pdf
document_name: docetaxel-teva-pharma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7972341
conversion_datetime: 2025-12-28 17:31:01.301847
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name                  | Strength   | Pharmaceutical                                         | Route of                       | Packaging                                                          | Content                                | Package size    |
|-----------------|-----------------------|------------|--------------------------------------------------------|--------------------------------|--------------------------------------------------------------------|----------------------------------------|-----------------|
| EU/1/10/662/001 | Docetaxel TEVA Pharma | 20 mg      | Form Concentrate and solvent for solution for infusion | Administration Intravenous use | concentrate: vial (glass); solvent: vial (glass) ml; ml authorised | concentrate: 0,72 solvent: 1,28        | 1 vial + 1 vial |
| EU/1/10/662/002 | Docetaxel TEVA Pharma | 80 mg      | Concentrate and solvent for solution for infusion      | Intravenous use                | concentrate: vial (glass); solvent: vial (glass)                   | concentrate: 2,88 ml; solvent: 5,12 ml | 1 vial + 1 vial |

<!-- image -->